Hefei Lifeon Pharmaceutical Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.343x

Hefei Lifeon Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Hefei Lifeon Pharmaceutical Co Ltd (003020) has a cash flow conversion efficiency ratio of 0.343x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥667.63 Million ≈ $97.69 Million USD) by net assets (CN¥1.95 Billion ≈ $284.68 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Hefei Lifeon Pharmaceutical Co Ltd (2012–2025)

Cash flow conversion efficiency of Hefei Lifeon Pharmaceutical Co Ltd from 2012 to 2025. This chart illustrates how Hefei Lifeon Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Hefei Lifeon Pharmaceutical Co Ltd stock price today for real-time trading data and today's change.

Hefei Lifeon Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained

Hefei Lifeon Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Hefei Lifeon Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hefei Lifeon Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see market cap of Hefei Lifeon Pharmaceutical Co Ltd for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Qualipoly Chemical Corp TW:4722	-0.027x
AUPU Home Style Corp Ltd SHG:603551	0.023x
HeNan Splendor Science & Technology Co Ltd SHE:002296	0.019x
Allied Properties Real Estate Investment Trust TO:AP-UN	0.009x
Taiwan Chinsan Electronic Industrial Co Ltd TWO:8042	0.042x
Sprout Social Inc NASDAQ:SPT	0.117x
PNE AG XETRA:PNE3	-0.170x
Soulbrain Holdings Co. Ltd KQ:036830	0.005x

Annual Cash Flow Conversion Efficiency for Hefei Lifeon Pharmaceutical Co Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Hefei Lifeon Pharmaceutical Co Ltd from 2012 to 2025. Review 003020 free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.95 Billion ≈ $285.59 Million	CN¥212.89 Million ≈ $31.15 Million	0.109x	+5.62%
2024-12-31	CN¥1.91 Billion ≈ $279.87 Million	CN¥197.53 Million ≈ $28.91 Million	0.103x	-5.00%
2023-12-31	CN¥1.87 Billion ≈ $274.15 Million	CN¥203.67 Million ≈ $29.80 Million	0.109x	-19.80%
2022-12-31	CN¥1.48 Billion ≈ $216.60 Million	CN¥200.64 Million ≈ $29.36 Million	0.136x	+11.37%
2021-12-31	CN¥1.30 Billion ≈ $190.80 Million	CN¥158.70 Million ≈ $23.22 Million	0.122x	-17.16%
2020-12-31	CN¥1.17 Billion ≈ $171.79 Million	CN¥172.49 Million ≈ $25.24 Million	0.147x	-41.94%
2019-12-31	CN¥590.00 Million ≈ $86.34 Million	CN¥149.30 Million ≈ $21.85 Million	0.253x	+98.55%
2018-12-31	CN¥505.70 Million ≈ $74.00 Million	CN¥64.45 Million ≈ $9.43 Million	0.127x	+307.11%
2017-12-31	CN¥361.71 Million ≈ $52.93 Million	CN¥11.32 Million ≈ $1.66 Million	0.031x	-84.18%
2016-12-31	CN¥298.09 Million ≈ $43.62 Million	CN¥58.99 Million ≈ $8.63 Million	0.198x	-53.66%
2014-12-31	CN¥215.53 Million ≈ $31.54 Million	CN¥92.05 Million ≈ $13.47 Million	0.427x	+112.57%
2013-12-31	CN¥176.88 Million ≈ $25.88 Million	CN¥35.54 Million ≈ $5.20 Million	0.201x	+458.44%
2012-12-31	CN¥141.96 Million ≈ $20.77 Million	CN¥-7.96 Million ≈ $-1.16 Million	-0.056x	--

About Hefei Lifeon Pharmaceutical Co Ltd

SHE:003020 China Biotechnology

Market Cap

$493.59 Million

CN¥3.37 Billion CNY

Market Cap Rank

#11928 Global

#3381 in China

Share Price

CN¥14.78

Change (1 day)

-0.40%

52-Week Range

CN¥14.66 - CN¥31.69

All Time High

CN¥38.76